CVC Strategic Opportunities to take 50 percent stake in DFE

CVC Strategic Opportunities has agreed to acquire a 50 percent stake in DFE Pharma, a German excipients manufacturer for the pharmaceutical industry. The seller is Fonterra. No financial terms were disclosed.

ByIris Dorbian

25 September 2019•3 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.

Deals North America US Healthcare Briefs

CVC Strategic Opportunities to take 50 percent stake in DFE

Related articles